Elisabeth Buur Stougaard (Elisabeth B Stougaard)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Smoking Cessation

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

Diabetes & vascular disease research

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabeth Buur Stougaard, Ellen Burgess, Dorte Vistisen, Phillip Banks, Manon Girard, Michael J Davies, Frederik Persson
Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Elisabeth Buur Stougaard, Ellen Burgess, Dorte Vistisen, Phillip Banks, Manon Girard, Michael J Davies, Frederik Persson
Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and kidney disease as assessed by Steno T1 Risk Engine in adults with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Elisabeth Buur Stougaard, Hanan Amadid, Esben Søndergaard, Bendix Carstensen, Marit Eika Jorgensen, Kirsten Nørgaard, Ellen Burgess, Stephen C Bain, Dorte Vistisen
Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes-A Nationwide Danish Register Study. Diabetes care (2023)
Elisabeth Buur Stougaard, Peter L Kristensen, Urd Kielgast, Henrik U Andersen, Yasmin Hamid, Peter H Gæde, Esben Søndergaard, Gry H Dørflinger, Karen K Fjeldborg, Klavs W Hansen, Henrik H Thomsen, Thuraya M J Al-Imar, Michael Røder, Vikas S Sridhar, David Cherney, Peter Rossing, Frederik Persson
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis. Diabetes & vascular disease research 19 (5) (2022)
Elisabeth Buur Stougaard, Signe Abitz Winther, Hanan Amadid, Marie Frimodt-Møller, Frederik Persson, Tine Willum Hansen, Peter Rossing
Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes. PloS one 16 (7) (2021)